Collegium Pharmaceutical (COLL) EBITDA Margin (QoQ) (2016 - 2026)
Collegium Pharmaceutical (COLL) EBITDA Margin (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 898.51 Mn | 749.20 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,268.00 |
| Mar 31, 2026 | -1,361.00 |
| Dec 31, 2025 | -8.00 |
| Sep 30, 2025 | 1,098.00 |
| Jun 30, 2025 | 647.00 |
| Mar 31, 2025 | -9,014.00 |
| Dec 31, 2024 | 8,047.00 |
| Sep 30, 2024 | -1,081.00 |
| Jun 30, 2024 | -146.00 |
| Mar 31, 2024 | -706.00 |
| Dec 31, 2023 | 827.00 |
| Sep 30, 2023 | 664.00 |
| Jun 30, 2023 | 928.00 |
| Mar 31, 2023 | 865.00 |
| Dec 31, 2022 | -776.00 |
| Sep 30, 2022 | 712.00 |
| Jun 30, 2022 | 2,095.00 |
| Mar 31, 2022 | 7,707.00 |
| Dec 31, 2021 | -10,697.00 |
| Sep 30, 2021 | -184.00 |